# NLRP10 engages oxidized DNA through a Schiff-base mechanism and dissociates from NLRP3 upon inflammasome activation

**Authors:** Julia Elise Cabral, Angela Lackner, Wenjin Jiang, Sophia Lin, Haitian Zhou, Anna Wu, Courtney Demos, Minh Anh Pham, Reginald McNulty

PMC · DOI: 10.1038/s42003-025-09501-x · Communications Biology · 2026-01-22

## TL;DR

NLRP10 interacts with NLRP3 and cleaves oxidized mitochondrial DNA, influencing innate immunity and potentially inflammatory diseases.

## Contribution

NLRP10's DNA cleavage mechanism via a Schiff base and its dissociation from NLRP3 during inflammasome activation is newly revealed.

## Key findings

- NLRP3 is involved in releasing D-loop mtDNA into the cytosol.
- NLRP10 cleaves oxidized DNA using a Schiff base mechanism.
- NLRP10's activity may influence senescence and inflammasome activation.

## Abstract

Mitochondrial DNA release into the cytosol is a critical event in innate immune activation, often acting as a damage-associated molecular pattern (DAMP) that triggers inflammasome assembly. Here, we demonstrate that NLRP3 is involved in the release of D-loop mtDNA into the cytosol. We further show that NLRP3 interacts with NLRP10. NLRP10-mediated oxidized DNA cleavage involves a Schiff base intermediate and is inhibited by small molecules known to inhibit glycosylases. These findings support a model where NLRP10 interaction with oxidized DNA may contribute to long-term senescence secretory phenotype and modulate inflammasome activation. Our study highlights a novel mechanism by which NLRP10 can respond to mitochondrial stress signals to influence innate immunity and suggests therapeutic potential for targeting these interactions in inflammatory diseases.

The cytosolic innate immune sensor NLRP10 interacts with NLRP3 and mediates the cleavage of oxidized mitochondrial DNA

## Linked entities

- **Genes:** NLRP10 (NLR family pyrin domain containing 10) [NCBI Gene 338322], NLRP3 (NLR family pyrin domain containing 3) [NCBI Gene 114548]

## Full-text entities

- **Genes:** IL1B (interleukin 1 beta) [NCBI Gene 3553] {aka IL-1, IL1-BETA, IL1F2, IL1beta}, POTEF (POTE ankyrin domain family member F) [NCBI Gene 728378] {aka A26C1B, POTE2alpha, POTEACTIN}, OGG1 (8-oxoguanine DNA glycosylase) [NCBI Gene 4968] {aka HMMH, HOGG1, MUTM, OGH1}, RELA (RELA proto-oncogene, NF-kB subunit) [NCBI Gene 5970] {aka AIF3BL3, CMCU, NFKB3, p65}, GAPDH (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 2597] {aka G3PD, GAPD, HEL-S-162eP}, PYCARD (PYD and CARD domain containing) [NCBI Gene 29108] {aka ASC, CARD5, TMS, TMS-1, TMS1}, NLRP3 (NLR family pyrin domain containing 3) [NCBI Gene 114548] {aka AGTAVPRL, AII, AVP, C1orf7, CIAS1, CLR1.1}, MLRL (Myeloid leukemia-related gene (myeloid tumor suppressor)) [NCBI Gene 8201] {aka MLRG, MTS}, NLRP10 (NLR family pyrin domain containing 10) [NCBI Gene 338322] {aka CLR11.1, NALP10, NOD8, PAN5, PYNOD}, IL18 (interleukin 18) [NCBI Gene 3606] {aka IGIF, IL-18, IL-1g, IL1F4}, MEFV (MEFV innate immunity regulator, pyrin) [NCBI Gene 4210] {aka FMF, MEF, PAAND, TRIM20}, NFKBIA (NFKB inhibitor alpha) [NCBI Gene 4792] {aka EDAID2, IKBA, MAD-3, NFKBI}, CGAS (cyclic GMP-AMP synthase) [NCBI Gene 115004] {aka C6orf150, D4, MB21D1, h-cGAS}, NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790] {aka CVID12, EBP-1, KBF1, NF-kB, NF-kB1, NF-kappa-B1}, PYDC1 (pyrin domain containing 1) [NCBI Gene 260434] {aka ASC2, POP1, PYC1, cPOP1}, CASP1 (caspase 1) [NCBI Gene 834] {aka ICE, IL1BC, P45}, Nlrp3 (NLR family, pyrin domain containing 3) [NCBI Gene 216799] {aka AGTAVPRL, AII/AVP, Cias1, FCAS, FCU, MWS}, Nlrp10 (NLR family, pyrin domain containing 10) [NCBI Gene 244202] {aka 6430548I20Rik, Nalp10, Napl10, PAN5, Pynod}, MAVS (mitochondrial antiviral signaling protein) [NCBI Gene 57506] {aka CARDIF, IPS-1, IPS1, VISA}, POP1 (POP1 ribonuclease P/MRP subunit) [NCBI Gene 10940] {aka ANXD2}, NLRP11 (NLR family pyrin domain containing 11) [NCBI Gene 204801] {aka CLR19.6, NALP11, NOD17, PAN10, PYPAF6, PYPAF7}, STING1 (stimulator of interferon response cGAMP interactor 1) [NCBI Gene 340061] {aka ERIS, MITA, MPYS, NET23, SAVI, STING}
- **Diseases:** mitochondrial damage (MESH:D028361), neurodegeneration (MESH:D019636), fibrosis (MESH:D005355), cancer (MESH:D009369), NLR (MESH:D020191), mitochondrial distress (MESH:D012128), CAPS (MESH:D056587), inflammation (MESH:D007249)
- **Chemicals:** phenol red (MESH:D010637), TH5487 (MESH:C000712208), DEPC (MESH:D004047), SDS (MESH:D012967), guanine (MESH:D006147), sodium borohydride (MESH:C025364), imidazole (MESH:C029899), lipid (MESH:D008055), Alexa Fluor 488 (MESH:C000711379), agarose (MESH:D012685), amino acids (MESH:D000596), KOH (MESH:C029943), nigericin (MESH:D009550), MgCl2 (MESH:D015636), DMEM (-), 8-oxoguanine (MESH:C024829), Glutamine (MESH:D005973), glycine (MESH:D005998), Streptomycin (MESH:D013307), EDTA (MESH:D004492), 8-oxo-dG (MESH:D000080242), Ponceau S. (MESH:C032756), potassium phosphate (MESH:C013216), Triton X-100 (MESH:D017830), Mannitol (MESH:D008353), NP-40 (MESH:C010615), Schiff base (MESH:D012545), Tween (MESH:D011136), Penicillin (MESH:D010406), cardiolipin (MESH:D002308), sucrose (MESH:D013395), ATP (MESH:D000255), PVDF (MESH:C024865), glycerol (MESH:D005990), lysine (MESH:D008239), Cy5 (MESH:C085321), DTT (MESH:D004229), PBS (MESH:D007854), ethidium bromide (MESH:D004996), CO2 (MESH:D002245), ATPgammaS (MESH:C022571), LPS (MESH:D008070), water (MESH:D014867), NaCl (MESH:D012965), Trypan Blue (MESH:D014343), HEPES (MESH:D006531), MCC950 (MESH:C000597426), Bis-Tris (MESH:C026272)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606]
- **Mutations:** E0554S, start at 98, K249Q
- **Cell lines:** Expi293 — Homo sapiens (Human), Transformed cell line (CVCL_D615), THP-1 — Homo sapiens (Human), Childhood acute monocytic leukemia, Cancer cell line (CVCL_0006), THP-1s — Mus musculus (Mouse), Hybridoma (CVCL_U609), DH5alpha — Drosophila hydei (Fruit fly), Spontaneously immortalized cell line (CVCL_Z531)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12827243/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12827243/full.md

## References

4 references — full list in the complete paper: https://tomesphere.com/paper/PMC12827243/full.md

---
Source: https://tomesphere.com/paper/PMC12827243